ENTITY
Biogen Inc

Biogen Inc (BIIB US)

153
Analysis
Health Care • United States
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
more
Company Presentation • 29 Apr 2026 20:00

Q1 2026

Company Presentation • 31 Mar 2026 20:30

M&A announcement

Company Presentation • 13 Jan 2026 05:30

44th Annual J.P. Morgan Healthcare Conference

Company Presentation • 13 Mar 2021 20:00

Investor Update

Company Presentation • 20 Oct 2021 08:00

Q3 2021

x